Recro pharma, inc. (REPH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Schedule Of Defined Benefit Plans Disclosures [Table]
Defined Benefit Plan Disclosure [Line Items]
Cash flows from operating activities, continuing operations:
Net loss

-24,345

-18,630

-50,418

-59,365

-69,245

-79,723

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on discontinued operations

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-31,753

-30,205

0

0

0

-

-

-

-

-

-

-

-

Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities from continuing operations:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15,124

-16,134

0

0

0

Stock-based compensation

7,608

6,191

5,955

6,161

4,509

4,279

5,163

5,111

4,870

4,178

5,355

4,829

4,080

3,889

4,138

3,757

3,532

3,064

1,926

1,093

744

531

0

0

0

Non-cash interest expense

5,855

5,412

4,191

3,062

1,985

1,287

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

933

1,071

0

0

0

-

-

-

-

-

-

-

-

Depreciation expense

6,000

5,817

5,709

5,404

4,973

4,872

4,957

4,867

4,813

4,793

4,892

4,906

4,918

4,993

0

0

0

-

-

-

-

-

-

-

-

Amortization of intangible assets

2,583

2,583

2,583

2,583

2,583

2,583

2,584

2,583

2,583

2,583

2,583

2,584

2,583

2,583

0

0

0

-

-

-

-

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,272

0

0

0

Change in warrant valuation

-

2,116

1,301

1,428

-752

284

-84

437

491

9

-405

-812

1,512

-373

0

0

0

-

-

-

-

-

-

-

-

Change in contingent consideration valuation

-

-

-

-

-

-

0

0

12,545

-

11,346

10,989

9,564

9,728

0

0

0

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-17,637

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-2,252

-1,423

0

0

0

-

-

-

-

-

-

-

-

Inventory

1,876

4,373

2,740

1,526

140

860

290

1,225

2,218

1,093

79

159

171

-237

0

0

0

-

-

-

-

-

-

-

-

Contract asset

4,644

3,650

3,178

1,288

-400

1,446

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-1,166

604

294

1,831

2,112

508

-1,594

-1,194

-1,187

243

1,081

681

666

325

0

0

0

-

-

-

-

-

-

-

-

Right-of-use asset

-199

-207

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-1,732

1,523

4,472

6,125

6,385

3,180

-1,381

1,569

-2,445

-725

702

-1,365

109

1,831

0

0

0

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

521

-364

-5,026

-8,309

5,413

-858

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

-205

-213

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

942

827

-79

585

0

0

0

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44

51

0

0

0

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

3,467

-

-

-

4,243

-

2,219

4,158

1,326

1,100

0

0

0

Net cash provided by operating activities, continuing operations

0

-

-

-

0

-

-

-

-

-

-

-

-7,894

-3,202

-3,579

1,363

8,979

8,458

3,620

-6,446

-13,017

-10,866

0

0

0

Cash flows from investing activities, continuing operations:
Purchases of property and equipment

6,313

8,342

12,478

13,375

8,193

7,198

5,180

5,149

5,313

5,403

6,342

5,874

5,170

3,770

0

0

0

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

12,100

12,020

13,264

13,265

6,225

7,723

8,513

25,988

57,124

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturity of investments

-

-

-

-

-

9,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in)/provided by investing activities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities, continuing operations

0

-

-

-

0

-

-

-

-

-

-

-

-41,287

-3,770

0

0

0

-

-

-

-

-

-

-

-

Cash flows from financing activities, continuing operations:
Proceeds from initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from Aspire facility

-

-

-

-

-

-

-

-

-

-

-

-

-

7,796

0

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of long-term debt, net of original issue discount of $11,400

-

43,600

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

6,324

0

0

0

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

2,936

3,636

3,636

3,636

961

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net of transaction costs

-

-

-

-

-

16,965

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of withholdings on shares withheld for income taxes

1,963

1,676

1,029

978

869

91

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Proceeds from option exercises

5,947

6,003

3,309

1,882

1,936

1,815

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

175

0

0

0

Net cash provided by/(used in) financing activities, continuing operations

0

-

-

-

0

-

-

-

-

-

-

-

-

51,676

2,694

90

44,792

46,740

55,227

48,188

-297

30,535

0

0

0

Net increase in cash and cash equivalents from continuing operations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operations:
Cash flows used in operating activities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows used in investing activities

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows used in financing activities

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents from discontinued operations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

0

26,799

-

-12,949

-6,117

4,568

44,704

-3,523

-842

-1,673

97

4,371

-12,144

-13,314

19,669

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for interest

15,354

14,395

12,521

10,403

8,322

8,134

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of notes payable and accrued interest into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Conversion of Series A and accrued dividends into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,150

0

0

0

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

4,328

4,517

0

0

0

-

-

-

-

-

-

-

-

Unrealized loss on available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property, plant and equipment included in accrued expenses and accounts payable

-148

288

-863

2,050

3,190

2,301

2,646

358

247

235

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Retirement of fully depreciated property, plant and equipment

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued in connection with equity facility

-

301

301

301

301

357

0

0

0

-

-

-

-

-

-

-

-

285

0

0

0

-

-

-

-